User profiles for M. Metersky
mark meterskyProfessor of Medicine, University of Connecticut School of Medicine Verified email at uchc.edu Cited by 16120 |
[HTML][HTML] Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
ML Metersky, RG Masterton, H Lode, TM File Jr… - International Journal of …, 2012 - Elsevier
Post-influenza bacterial pneumonia is a major cause of morbidity and mortality associated
with both seasonal and pandemic influenza virus illness. However, despite much interest in …
with both seasonal and pandemic influenza virus illness. However, despite much interest in …
Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies
…, C Luna, T Maruyama, R Menendez, M Metersky… - Chest, 2020 - Elsevier
Background Community-acquired pneumonia (CAP) guidelines have improved the treatment
and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. …
and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. …
Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases …
…, SA Flanders, MR Griffin, ML Metersky… - American journal of …, 2019 - atsjournals.org
Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …
management of adult patients with community-acquired pneumonia. Methods: A …
[HTML][HTML] Cyclophosphamide versus placebo in scleroderma lung disease
…, B Fessler, N Rothfield, M Metersky - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a double-blind, randomized, placebo-controlled trial to determine
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
the effects of oral cyclophosphamide on lung function and health-related symptoms in …
A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis
…, ML Metersky, PA Flume, SA Lewis, M McKevitt… - Chest, 2014 - Elsevier
… Drs Salathe, Ilowite, and Metersky have reported that no potential conflicts of interest exist
with any companies/organizations whose products or services may be discussed in this article…
with any companies/organizations whose products or services may be discussed in this article…
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
…, B Fessler, N Rothfield, M Metersky… - American journal of …, 2007 - atsjournals.org
Rationale: The Scleroderma Lung Study enrolled 158 patients with scleroderma-related
interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although …
interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although …
Hospital‐acquired pressure ulcers: results from the national Medicare patient safety monitoring system study
CH Lyder, Y Wang, M Metersky, M Curry… - Journal of the …, 2012 - Wiley Online Library
… M. Metersky's employer is remunerated for his quality insurance and safety work with …
Author Contributions: Study concept and design: Courtney Lyder, Mark Metersky, Nancy Verzier, …
Author Contributions: Study concept and design: Courtney Lyder, Mark Metersky, Nancy Verzier, …
Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry
…, M Johnson, E Eden, D Griffith, M Knowles, M Metersky… - Chest, 2017 - Elsevier
Objectives We sought to describe the characteristics of adult patients with bronchiectasis
enrolled in the US Bronchiectasis Research Registry (BRR). Methods The BRR is a database …
enrolled in the US Bronchiectasis Research Registry (BRR). Methods The BRR is a database …
[HTML][HTML] National trends in patient safety for four common conditions, 2005–2011
Y Wang, N Eldridge, ML Metersky… - … England Journal of …, 2014 - Mass Medical Soc
Background Changes in adverse-event rates among Medicare patients with common medical
conditions and conditions requiring surgery remain largely unknown. Methods We used …
conditions and conditions requiring surgery remain largely unknown. Methods We used …